10 Best Biotech Stocks Under $10 to Buy

Page 5 of 5

1. Ocular Therapeutix (NASDAQ:OCUL)

Number of Hedge Fund Holders: 49

Market Capitalization as of October 27: $1.48 Billion

Share Price as of October 27: $6.72

Ocular Therapeutix Inc. has struggled in 2026, with its shares down nearly 43% and underperforming the broader biotechnology sector, which has gained about 31%. Amid the selloff, UBS reiterated confidence in the company’s long-term prospects on October 11, asserting why it is one of the best biotech stocks under $10 to buy.

The research firm initiated coverage with a Buy rating and a $14 price target on October 11. According to the research firm, the lead asset, AXPAXLI, for wet age-related macular degeneration (wet AMD) could unlock substantial value and generate up to $3.3 billion in sales by 2035.

The sentiment comes as the company increasingly positions the lead investigational treatment to provide sustained drug delivery and reduce the frequency of injections required to manage retinal disease. The company is targeting an NDA submission in the fourth quarter, a milestone that could bring the treatment closer to commercialization. Is the stock a Buy on NDA catalyst?

Similarly, Ocular Therapeutix Inc. maintains a substantial cash position needed to support AXPAXLI commercial launch. It ended the second quarter with cash and cash equivalents of $600.2 million, up from $392.75 million in the same period last year.

Ocular Therapeutix’s underperformance reflects growing competitive concerns, high clinical expectations, and persistent financial losses, not definitive evidence that AXPAXLI has failed. Therefore, the stock can offer substantial upside to investors who can tolerate clinical and financing risk. Explore why the stock is positioned for growth.

While we acknowledge the potential of OCUL to grow, we believe certain AI infrastructure stocks offer far stronger long-term potential at a much more attractive entry point. If you are looking for an AI stock more promising than OCUL that operates as a critical AI tollbooth and stands as the most important company in the world, check out our report about this must-own AI stock.

READ NEXT: 10 Best Aerospace Dividend Stocks to Buy and 9 UK Dividend Growth Stocks to Consider.

Page 5 of 5